Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial

BACKGROUND: The PIROUETTE (PIRfenidOne in patients with heart failUre and preserved lEfT venTricular Ejection fraction) trial is designed to evaluate the efficacy and safety of the anti-fibrotic pirfenidone in patients with chronic heart failure and preserved ejection fraction (HFpEF) and myocardial...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cardiovasc Drugs Ther
Hoofdauteurs: Lewis, Gavin A., Schelbert, Erik B., Naish, Josephine H., Bedson, Emma, Dodd, Susanna, Eccleson, Helen, Clayton, Dannii, Jimenez, Beatriz Duran, McDonagh, Theresa, Williams, Simon G., Cooper, Anne, Cunnington, Colin, Ahmed, Fozia Zahir, Viswesvaraiah, Rajavarma, Russell, Stuart, Neubauer, Stefan, Williamson, Paula R., Miller, Christopher A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2019
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689029/
https://ncbi.nlm.nih.gov/pubmed/31069575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-019-06876-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items